Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease
-
Nxera Announces Successful Resolution of miniG Patent Infringement Action
-
Nxera Announces Successful Resolution of miniG Patent Infringement Action
-
AH Realty Trust to Report Third Quarter Earnings on November 2nd
-
Todd McEwen Tutoring to Launch Business English Services on November 26, 2026
-
Form 8.5 (EPT/RI) - Pharos Energy Plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Xyper Launches New Rewards Model for the Global Creator Economy
-
Kestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market Companies
-
American Battery Technology Company Receives Approval for Sale of $100 Million of Exported Recycled Black Mass Critical Minerals with License from U.S. Department of Commerce
-
CHUCK E. CHEESE ANNOUNCES BOO-TACULAR: LARGEST KID-FOCUSED HALLOWEEN CELEBRATION
-
Beam Europe Secures Approximately $4 Million in Q3 Smart City Infrastructure Orders
-
Enerflex Ltd. Announces Contract Award for Large-Scale Data Center Development
-
Origence Expands Lending Network with New Auto Refinance Solution for Credit Unions
-
Acuity Reports Fiscal 2026 Fourth-Quarter and Full-Year Results
-
Global Liver Institute’s 2026 #OctoberIs4Livers Campaign Calls for Action Across the Liver Cancer Journey
-
Townsquare and Lakes Media Network Announce Digital Advertising Partnership Serving Virginia and North Carolina
-
FAU’s MBA in Sport Management Ranks No. 7 Globally
-
Sompo appoints Scott Toland as Head of Commercial Lines, Insurance, Continental Europe
-
WasabiCard to Join TOKEN2049 Singapore 2026 as Gold Sponsor, Accelerating Stablecoin Payments at Scale
-
RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals
-
Global Net Lease, Inc. Announces Common Stock Dividend for the Fourth Quarter 2026
-
Vitalist Inc. Appoints Carley George as President
-
Information on share capital and voting rights - September 2026
-
Scandinavian Tobacco Group A/S completes the divestment of BREAK and Moro and raises the free cash flow guidance for 2026.
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SENIOR PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RHI MAGNESITA NV - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Man Group PLC : Form 8.3 - RHI Magnesita N.V.
-
Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development
-
Man Group PLC : Form 8.3 - Rotork plc
-
Man Group PLC : Form 8.3 - Sthree
-
Man Group PLC : Form 8.3 - Vesuvius Plc
-
Cash Flows
-
New Travel Industry Coalition Calls for EU Digital Omnibus to Enable Secure, Seamless Biometric Journeys
-
New Travel Industry Coalition Calls for EU Digital Omnibus to Enable Secure, Seamless Biometric Journeys
-
Hyster hydrogen fuel cell ReachStacker supports sustainable ports project at Rotterdam Short Sea Terminals
-
Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board
-
FTI Consulting Expands UK Turnaround & Restructuring Capabilities With Four Senior Hires
-
Contentstack Launches Contentstack Canoe, an AI Visibility Tool That Shows Brands What AI Tells Their Buyers
-
Huntress Accelerates European Expansion Through New ALSO Partnership
-
FTI Consulting Expands UK Turnaround & Restructuring Capabilities With Four Senior Hires
-
Ress Life Investments A/S publishes Net Asset Value (NAV).
-
Numab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer to Advance its Proprietary Multispecific Antibody Pipeline
-
Atrogi announces positive human data for ATR-258, its first-in-class, oral therapy designed to improve muscle function and body composition
-
DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform
-
Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and
